Verrica Pharmaceuticals Inc. (VRCA) Social Stream



Verrica Pharmaceuticals Inc. (VRCA): $2.50

0.33 (+15.21%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Verrica Pharmaceuticals Inc (VRCA) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering Verrica Pharmaceuticals Inc.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-15 6 $25 $16 $19.833 $8.48 133.88%
2021-12-16 6 $25 $16 $19.5 $8.48 129.95%
2022-03-03 4 $25 $16 $19.5 $8.48 129.95%
2022-03-07 5 $25 $16 $19.5 $8.48 129.95%
2022-03-09 6 $25 $16 $19.571 $8.48 130.79%

The Trend in the Analyst Price Target


Over the past 16 months, VRCA's average price target has gone up $2.07.

VRCA reports an average of 95.57% for its upside potential over the past 47 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-06-14 5 25 10 19.860 11.88 67.17%
2021-07-12 5 25 10 19.860 11.13 78.44%
2022-03-03 4 25 16 19.500 8.43 131.32%
2022-03-07 5 25 16 19.500 7.68 153.91%
2022-03-09 6 25 16 19.571 7.96 145.87%

VRCA Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.17 5 1 0 0 0 6

The Trend in the Broker Recommendations


Over the past 18 months, VRCA's average broker recommendation rating improved by 0.13.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • In the context of all US stocks, Verrica Pharmaceuticals Inc's upside potential (average analyst target price relative to current price) is greater than 409.86% of them.
  • To contextualize these metrics, consider that out of all US stocks, Verrica Pharmaceuticals Inc's average analyst price target is higher than 111.16% of them.
  • In the context of all US stocks, Verrica Pharmaceuticals Inc's number of analysts covering the stock is greater than 156.53% of them.
  • In terms of how Verrica Pharmaceuticals Inc fares relative to stocks in the small market cap category, note that its variance in analysts' estimates is lower than -212.73% of that group.

Stocks similar to Verrica Pharmaceuticals Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are VNDA, VKTX, and VINC.

What is the outlook for VRCA? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6312 seconds.